header-logo
Staff Collaborate Conference Room
Christopher M. Olsen, PhD
Christopher-Olsen-PhD

Christopher M. Olsen, PhD

Associate Professor, Director of Graduate Studies

Locations

  • Pharmacology and Toxicology

Contact Information

General Interests

Neuroscience, Addictive Behavior and Novelty Seeking

Education

PhD, Toxicology and Neuroscience, University of Texas, 2004
MS, Texas Tech University, 1998
BA, Baylor University, 1994

Research Experience

  • Brain Concussion
  • Brain Injuries
  • Brain Injury, Chronic
  • Cocaine-Related Disorders
  • Exploratory Behavior
  • Motivation
  • Opioid-Related Disorders
  • Substance-Related Disorders

MCW Program / Core Facilities

  • Neuroscience Research Center

Research Interests

Olsen Lab

Addiction is a chronically relapsing disorder that is strongly modulated by positive and negative environmental factors. Our lab (olsenlab.org) focuses on how these environmental factors can influence drug intake and drug seeking using rat and mouse models of addiction.

We have two major projects to investigate environmental factors and addiction:

Environmental modulation of drug seeking ensembles. Transgenic approaches are used to identify and manipulate cells that are engaged during drug seeking following intravenous drug self-administration. We are studying the effects of positive and negative environmental factors on drug seeking and the activity of cells within drug seeking ensembles.

The impact of mild traumatic brain injury (mTBI) on addiction and mesocorticolimbic function. This work is done in collaboration with Drs. Brain Stemper and Matthew Budde in the Department of Biomedical Engineering and Neurosurgery, respectively. We are examining the effects of mTBI on drug self-administration, drug seeking, and mesocorticolimbic function using diffusion tensor imaging (DTI) and functional connectivity.

View the full publication list.

Olsen Lab Image 1

Identification of neuronal ensembles involved in persistent drug seeking. TetTag (green) cells are those engaged during an initial drug seeking session, Fos+ (red) cells are those engaged during a second drug seeking session 2 weeks later.

Olsen Lab Image 2

Quantification of monocytes/microglia. Iba1+ (green) cells are surface rendered for complex analysis to examine long-lasting effect of mild traumatic brain injury on immune cells within the brain. Gray=nuclei (DAPI).

Publications

Publications of Christopher M. Olsen PhD from the Faculty Collaboration Database

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.